🇺🇸 FDA
Pipeline program

Gamma-retroviral vector MP71 MC2 TCR16-3D9

Phase 2 small_molecule active

Quick answer

Gamma-retroviral vector MP71 MC2 TCR16-3D9 for advanced melanoma or HNSCC is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
advanced melanoma or HNSCC
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials